Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT
Oxford Biomedica Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Oxford Biomedica stock has a consensus rating of "Strong Buy" and an average price target of 842p. The average 1-year stock price forecast is 47.53% higher than the current stock price, while the lowest is 550p (-3.68%) and the highest is 1,140p (+99.65%).
Price Target: 842p (+47.53%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 24, 2026.
Analyst Ratings
The average analyst rating for Oxford Biomedica stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates 1,170p → 1,140p | Buy | Reiterates | 1,170p → 1,140p | +99.65% | Jun 24, 2026 |
| Jefferies | Jefferies | Buy Reiterates 827p | Buy | Reiterates | 827p | +44.83% | Jun 3, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates 950p | Buy | Reiterates | 950p | +66.37% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
228.22M
from 168.74M
Increased by 35.25%
Revenue Next Year
288.55M
from 228.22M
Increased by 26.43%
EPS This Year
-0.12
from -0.27
EPS Next Year
0.12
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.